Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (321-330 of 597) with videos related to

Pageof 60
Sort By:
British Journal of Haematology|January 13, 2012
EZH2 mutations and their association with PICALM-MLLT10 positive acute leukaemiaVera Grossmann, Ulrike Bacher, Alexander Kohlmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 29, 2013
Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosisSabina Berezowska, Michael J Flaig, Franziska Ruëff, et al.
Leukemia|August 11, 2021
Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alterationLuca Vincenzo Cappelli, Manja Meggendorfer, Constance Baer, et al.
Blood|December 31, 2011
Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotypeClaudia Haferlach, Tamara Alpermann, Susanne Schnittger, et al.
British Journal of Haematology|February 1, 2011
Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterationsUlrike Bacher, Torsten Haferlach, Tamara Alpermann, et al.
Blood|June 29, 2010
Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC)Miriam Miesner, Claudia Haferlach, Ulrike Bacher, et al.
Haematologica|September 16, 2008
Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETOTobias Berg, Manfred Fliegauf, Jan Burger, et al.
Oncogene|January 28, 2005
Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotypeKai Neben, Susanne Schnittger, Benedikt Brors, et al.
Genes, Chromosomes & Cancer|January 24, 2013
The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALLVera Grossmann, Claudia Haferlach, Sandra Weissmann, et al.
Blood|January 13, 2010
High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemiaAndrea Kühnl, Nicola Gökbuget, Andrea Stroux, et al.
Pageof 60

Showing results (321-330 of 597) with videos related to

Sort By:
Pageof 60
British Journal of Haematology|January 13, 2012
EZH2 mutations and their association with PICALM-MLLT10 positive acute leukaemiaVera Grossmann, Ulrike Bacher, Alexander Kohlmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 29, 2013
Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosisSabina Berezowska, Michael J Flaig, Franziska Ruëff, et al.
Leukemia|August 11, 2021
Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alterationLuca Vincenzo Cappelli, Manja Meggendorfer, Constance Baer, et al.
Blood|December 31, 2011
Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotypeClaudia Haferlach, Tamara Alpermann, Susanne Schnittger, et al.
British Journal of Haematology|February 1, 2011
Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterationsUlrike Bacher, Torsten Haferlach, Tamara Alpermann, et al.
Blood|June 29, 2010
Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC)Miriam Miesner, Claudia Haferlach, Ulrike Bacher, et al.
Haematologica|September 16, 2008
Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETOTobias Berg, Manfred Fliegauf, Jan Burger, et al.
Oncogene|January 28, 2005
Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotypeKai Neben, Susanne Schnittger, Benedikt Brors, et al.
Genes, Chromosomes & Cancer|January 24, 2013
The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALLVera Grossmann, Claudia Haferlach, Sandra Weissmann, et al.
Blood|January 13, 2010
High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemiaAndrea Kühnl, Nicola Gökbuget, Andrea Stroux, et al.
Pageof 60